What Researchers Did
This clinical study reviewed the mechanisms and accumulating clinical data supporting hyperbaric oxygen therapy (HBOT) as an adjunct for chronic wound healing.
What They Found
Researchers found that hyperbaric oxygen therapy (HBOT) increases growth factors, local wound signaling, and promotes the release of endothelial progenitor cells from bone marrow. Clinical data support HBOT's ability to hasten wound healing and reduce amputation rates in diabetic ulcers, making it an effective adjunct modality for appropriate patients.
What This Means for Canadian Patients
Canadian patients with chronic wounds, particularly diabetic ulcers, may benefit from hyperbaric oxygen therapy (HBOT) as an additional treatment option. This therapy could potentially accelerate wound healing and reduce the risk of amputation when used appropriately.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The abstract does not detail specific limitations of the clinical data reviewed or the study itself.